RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
1-Year Return
25.98%
This Quarter Return
+16%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$434M
AUM Growth
+$154M
(+55%)
Cap. Flow
+$135M
Cap. Flow
% of AUM
31.23%
Top 10 Holdings %
Top 10 Hldgs %
39.11%
Holding
88
New
19
Increased
48
Reduced
6
Closed
13
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$24.6M |
| 2 |
AVDL
Avadel Pharmaceuticals
AVDL
|
$10.1M |
| 3 |
ITMN
INTERMUNE INC
ITMN
|
$9.54M |
| 4 |
AbbVie
ABBV
|
$6.94M |
| 5 |
UnitedHealth
UNH
|
$6.64M |
Top Sells
| 1 |
Health Care Select Sector SPDR Fund
XLV
|
$9.94M |
| 2 |
GENT
GENTIUM SPA ADS
GENT
|
$6.82M |
| 3 |
AET
Aetna Inc
AET
|
$4.27M |
| 4 |
Puma Biotechnology
PBYI
|
$2.89M |
| 5 |
Edwards Lifesciences
EW
|
$2.8M |
Sector Composition
| 1 | Healthcare | 79.37% |
| 2 | Industrials | 1.53% |
| 3 | Technology | 0.49% |
| 4 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Jazz Pharmaceuticals
JAZZ
$7.77B
| $2.74M | 0.63% |
19,750
+6,750
| +52% | +$936K |
|
52
Viatris
VTRS
$12B
| $2.59M | 0.6% |
53,000
+16,500
| +45% | +$806K |
|
53
Innoviva
INVA
$1.32B
| $2.58M | 0.59% |
103,313
+25,130
| +32% | +$627K |
|
54
Ultragenyx Pharmaceutical
RARE
$3.01B
| $2.52M | 0.58% |
+51,500
| New | +$2.52M |
|
55
Prothena Corp
PRTA
$442M
| $2.49M | 0.57% |
+65,000
| New | +$2.49M |
|
|
CERN
56
DELISTED
Cerner Corp
CERN
| $2.36M | 0.55% |
42,000
+8,000
| +24% | +$450K |
|
57
Regeneron Pharmaceuticals
REGN
$60.1B
| $2.25M | 0.52% |
+7,500
| New | +$2.25M |
|
|
CBST
58
DELISTED
CUBIST PHARMACEUTICALS INC
CBST
| $2.2M | 0.51% |
30,000
+12,500
| +71% | +$915K |
|
|
CSLT
59
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $2.12M | 0.49% |
+100,000
| New | +$2.12M |
|
|
RCPT
60
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $2.1M | 0.48% |
+50,000
| New | +$2.1M |
|
61
Pediatrix Medical
MD
$1.48B
| $2.01M | 0.46% |
32,500
+500
| +2% | +$31K |
|
|
ABCO
62
DELISTED
Advisory Board Co/The
ABCO
| $2M | 0.46% |
31,075
+6,575
| +27% | +$423K |
|
|
WX
63
DELISTED
WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX
| $1.94M | 0.45% |
52,500
+19,000
| +57% | +$700K |
|
|
KIN
64
DELISTED
Kindred Biosciences, Inc.
KIN
| $1.71M | 0.4% |
+92,500
| New | +$1.71M |
|
65
Alkermes
ALKS
$4.77B
| $1.57M | 0.36% |
35,500
+12,250
| +53% | +$540K |
|
66
Novavax
NVAX
$1.27B
| $1.47M | 0.34% |
16,250
+5,250
| +48% | +$476K |
|
67
Arrowhead Research
ARWR
$3.87B
| $1.23M | 0.28% |
+75,000
| New | +$1.23M |
|
|
ETRM
68
DELISTED
EnteroMedics Inc.
ETRM
| $1.18M | 0.27% |
619
+286
| +86% | +$547K |
|
|
INFI
69
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $1.16M | 0.27% |
97,500
+1,500
| +2% | +$17.8K |
|
70
Vertex Pharmaceuticals
VRTX
$102B
| $1.13M | 0.26% |
16,000
-4,000
| -20% | -$283K |
|
|
AVNR
71
DELISTED
AVANIR PHARMACEUTICALS, INC CL A
AVNR
| $1.1M | 0.25% |
300,000
| – | – |
|
|
GWPH
72
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $1.05M | 0.24% |
+17,750
| New | +$1.05M |
|
73
Exelixis
EXEL
$10.1B
| $881K | 0.2% |
249,000
+99,000
| +66% | +$350K |
|
|
CNCE
74
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $801K | 0.18% |
+59,553
| New | +$801K |
|
|
75
Puma Biotechnology
PBYI
$257M
| $388K | 0.09% |
3,728
-27,772
| -88% | -$2.89M |
|